Signal transduction systems and atrial fibrillation

Cardiovascular Research

Volumn 54, Issue 2, 2002, Pages 247-258

  Goette, Andreas ^a   Lendeckel, Uwe ^a   Klein, Helmut U ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Angiotensin; Protein kinases; Receptors; Signal transduction; Supraventr. arrhythmia

Indexed keywords

ADRENALIN; ALDOSTERONE; ANGIOTENSIN; BRADYKININ; CATECHOLAMINE; CYTOKINE; ENDOTHELIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; G PROTEIN COUPLED RECEPTOR; GROWTH HORMONE; HORMONE; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTRANSMITTER; NITRIC OXIDE; NORADRENALIN; PEPTIDE; PLATELET DERIVED GROWTH FACTOR; RECEPTOR; SOMATOMEDIN; STEROID; THYROXINE; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; TYROSINE KINASE RECEPTOR; VASCULOTROPIN;

CELL ADHESION; CELL COMMUNICATION; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART CONDUCTION; HEART ELECTROPHYSIOLOGY; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; ATRIAL FIBRILLATION; CELL ADHESION MOLECULES; ENZYME ACTIVATION; HUMANS; HYPERTROPHY; MAP KINASE SIGNALING SYSTEM; MYOCARDIUM; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 0036220498     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(01)00521-1     Document Type: Review

References (112)

1. Chronic rapid atrial pacing: Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation
2. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats
3. Electrical remodeling in atrial fibrillation: Time course and mechanisms
4. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat
5. Dedifferentiation of atrial cardiomyocytes as a result of chronic atrial fibrillation
6. Histological substrate of atrial biopsies in patients with lone atrial fibrillation
7. Promotion of atrial fibrillation by heart failure in dogs. Atrial remodeling of a different sort
8. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart
9. Wavelength and conduction inhomogeneity in each atrium in patients with isolated mitral valve disease and atrial fibrillation
10. The amount of atrial fibrosis predicts the occurrence of atrial fibrillation after open-heart surgery
11. Nerve sprouting and sympathetic hyperinnervation in a canine model of atrial fibrillation produced by prolonged right atrial pacing
12. Myocardial cell death in fibrillating and dilated human right atria
13. Signal transduction underlying arrhythmogenic atrial remodeling due to congestive heart failure
14. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans
15. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation
16. Expression and activity of ectopeptidases in fibrillating human atria
17. Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm
18. G-protein-coupled receptors: Molecular mechanisms involved in receptor activation and selectivity of G-protein recognition
19. Heterotrimeric G proteins: Organizers of transmembrane signals
20. G protein-coupled receptor kinases
21. Angiotensin II receptors and angiotensin II-stimulated signal transduction
22. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression
23. Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts
24. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts
25. ACE inhibition in cardiovascular diseases
26. Angiotensin II-forming pathways in normal and failing hearts
27. Converting enzyme determines plasma clearance of angiotensin-(1-7)
28. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9
29. Regulation of the ERK subgroup of MAP kinase cascade through G protein-coupled receptors
30. P38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy
31. Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction
32. Molecular and cellular mechanisms of action of angiotensin II (AT1) receptors in vascular smooth muscle
33. Cell type-specific angiotensin II-evoked signal transduction pathways: Critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts
34. Angiotensin II signal transduction and the mitogen-activated protein kinase pathway
35. Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation
36. Direct stimulation of the Jak/STAT pathway by the angiotensin II AT1 receptor
37. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases
38. Angiotensin converting enzyme in the human heart: Effect of the deletion/insertion polymorphism
39. Is ACE gene polymorphism associated with lone atrial fibrillation?
40. Prevalence of atrial fibrillation in elderly subjects
41. Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes
42. Role of apoptosis and tissue fibrosis in arrhyhmogenic atrial structural remodeling in a canine model of congestive heart failure
43. Atrial tachycardia-induced remodeling in the presence of a substrate for atrial fibrillation: The whole differs from the sum of its parts
44. Atrial fibrillation in mitral stenosis: Histologic, hemodynamic and metabolic factors
45. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation
46. Structural remodeling of the left atrial appendage in patients with chronic non-valvular atrial fibrillation: Implications for thrombus formation, systemic embolism, and assessment by transesophageal echocardiography
47. Effects of lisinopril in patients with heart failure and chronic atrial fibrillation
48. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction
49. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation
50. 2+ channels in rat portal vein myocytes
51. + current in rabbit vascular myocytes
52. Correlation between changes in morphology, electrical properties and angiotensin converting enzyme activity in the failing heart
53. Gap junction remodeling in relation to stabilization of atrial fibrillation in the goat
54. Bioregulation of kinins: Kallikreins, kininogens, and kininases
55. Kallidin- and bradykinin-degrading pathways in human heart: Degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase
56. Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: An interspecies study
57. Contribution of bradykinin to the cardioprotective action of angiotensin converting enzyme inhibition in hypertension and after myocardial infarction
58. Effects of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: Role of kinins and angiotensin type 2 receptors
59. Molecular and cellular biology of endothelin and its receptors, parts I and II
60. Clinical significance of endothelin in cardiovascular disease
61. Endothelin system in human persistent and paroxysmal atrial fibrillation
62. Changes of plasma endothelin and atrial natriuretic peptide during the onset and after termination of paroxysmal supraventricular tachycardia
63. Verapamil reduces the arrhythmogenic effect of endothelin
64. Modulation of endothelin-1 effects on rat hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP
65. BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria
66. Adrenergic receptors: Evolving concepts and clinical applications
67. α1-Adrenergic receptor subtypes: Molecular structure, function, and signaling
68. Switching of the coupling of the β2-adrenergic receptor to different G proteins by kinase A
69. 2 adrenergic receptor-src protein kinase complex
70. Atrial fibrillation by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation
71. Verapamil prolongs atrial fibrillation by evoking an intense sympathetic neurohumoral effect
72. Effects of verapamil on atrial fibrillation and its electrophysiological determinants in dogs
73. Relation between ligament of Marshall and adrenergic atrial tachyarrhythmia
74. Effect of heavy exercise on platelet aggregability and endothelial function in patients with chronic atrial fibrillation
75. Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation
76. Effect of inotropic stimulation on left atrial appendage function in atrial myopathy of chronic atrial fibrillation
77. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation
78. Dihydropyridine and beta adrenergic receptor binding in dogs with tachycardia-induced atrial fibrillation
79. 2+-channel, β-adrenoreceptor, and 5-hydroxytryptamine type 4 receptor mRNAs in human atrial fibrillation
80. Evidence that angiotensin II enhances noradrenaline releases from sympathetic nerves in mouse atria by activating protein kinase C
81. Selective downregulation of the angiotensin II AT-1 receptor subtype in failing human ventricular myocardium
82. 2+-induced regulation of ion channel and MAP kinase function
83. Serum levels of vascular endothelial growth factor and transforming growth factor-beta1 in patients with atrial fibrillation undergoing defibrillation therapy
84. Temporal gradient in shear but not steady shear stress induces PDGF-A and MCP-1 expression in endothelial cells: Role of NO, NF kappa, and egr-1
85. Role of transforming growth factor-β in human disease
86. Mad connection to the nucleus
87. Transforming growth factor-β signal transduction
88. Peptide growth factors can provoke fetal contractile proteins gene expression in rat cardiac myocytes
89. Atrial expression of pro-inflammatory cytokines during chronic atrial fibrillation in humans
90. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart
91. Cytokines in myocarditis and cardiomyopathies
92. Apoptosis of ventricular and atrial myocytes from pacing-induced canine heart failure
93. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
94. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation
95. Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation
96. Angiotensin II and aldosterone regulation
97. Mineralocorticoid receptor affects AP-1 and nuclear factor-kappaB activation in angiotensin II-induced cardiac injury
98. Aldosterone escape during angiotensin converting enzyme inhibitor therapy in chronic heart failure
99. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients
100. Aldosterone production is activated in failing ventricle in humans
101. Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation
102. Aldosterone induces angiotensin converting enzyme gene expression in cultured neonatal rat cardiocytes
103. Integrins in morphogenesis and signaling
104. Angiotensin II, adhesion, and cardiac fibrosis
105. The effect of aspirin on thrombin stimulated platelet adhesion receptor expression and the role of neutrophils
106. Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation. Role of nitric oxide
107. Increased expression of P-selectin during chronic atrial fibrillation
108. Focal adhesion kinase is abundant in developing blood vessels and elevation of its phosphotyrosine content in vascular smooth muscle cells is a rapid response to angiotensin II
109. Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin alpha5beta3
110. Increased expression of ADAMs in patients with chronic atrial fibrillation
111. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study
112. Matrix metalloproteinase expression and activity in isolated myocytes after neurohumoral stimulation